Chronic lymphocytic leukaemia

TJ Kipps, FK Stevenson, CJ Wu, CM Croce… - Nature reviews Disease …, 2017 - nature.com
Chronic lymphocytic leukaemia (CLL) is a malignancy of CD5+ B cells that is characterized
by the accumulation of small, mature-appearing lymphocytes in the blood, marrow and …

Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia

EE Ladikou, T Chevassut, CJ Pepper… - British journal of …, 2020 - Wiley Online Library
Acute myeloid leukaemia (AML) is the most common adult acute leukaemia with the lowest
survival rate. It is characterised by a build‐up of immature myeloid cells anchored in the …

Treatment with Ibrutinib Inhibits BTK- and VLA-4–Dependent Adhesion of Chronic Lymphocytic Leukemia Cells In Vivo

SEM Herman, RZ Mustafa, J Jones, DH Wong… - Clinical Cancer …, 2015 - AACR
Purpose: Ibrutinib leads to a transient lymphocytosis in patients with chronic lymphocytic
leukemia (CLL) that develops within hours of starting drug and is due to the efflux of cells …

Lectin binding to surface Ig variable regions provides a universal persistent activating signal for follicular lymphoma cells

A Linley, S Krysov, M Ponzoni… - Blood, The Journal …, 2015 - ashpublications.org
The vast majority of cases of follicular lymphoma (FL), but not normal B cells, acquire N-
glycosylation sites in the immunoglobulin variable regions during somatic hypermutation …

Heightened BTK-dependent cell proliferation in unmutated chronic lymphocytic leukemia confers increased sensitivity to ibrutinib

A Guo, P Lu, N Galanina, C Nabhan, SM Smith… - …, 2015 - pmc.ncbi.nlm.nih.gov
In chronic lymphocytic leukemia (CLL), patients with unmutated immunoglobulin heavy
chain variable region gene (UM-CLL) have worse outcomes than mutated CLL (M-CLL) …

Phenotype and immune function of lymph node and peripheral blood CLL cells are linked to transendothelial migration

M Pasikowska, E Walsby, B Apollonio… - Blood, The Journal …, 2016 - ashpublications.org
Several lines of evidence suggest that homing of tumor cells to lymphoid tissue contributes
to disease progression in chronic lymphocytic leukemia (CLL). Here, we demonstrate that …

CD 49d associates with nodal presentation and subsequent development of lymphadenopathy in patients with chronic lymphocytic leukaemia

P Strati, SA Parikh, KG Chaffee… - British journal of …, 2017 - Wiley Online Library
CD 49d is a surface integrin that is expressed on chronic lymphocytic leukaemia (CLL) cells,
and strongly correlates with more aggressive disease. Given its association with cell‐cell …

[HTML][HTML] Combined CXCR3/CXCR4 measurements are of high prognostic value in chronic lymphocytic leukemia due to negative co-operativity of the receptors

S Ganghammer, J Gutjahr, E Hutterer, PW Krenn… - …, 2016 - ncbi.nlm.nih.gov
The mutational status of immunoglobulin heavy-chain variable-region (IGVH) genes is
considered the most powerful marker of clinical outcome in CLL. 5, 6 However, patients with …

Prognostic significance of translocations in the presence of mutated IGHV and of cytogenetic complexity at diagnosis of chronic lymphocytic leukemia

NA Heerema, N Muthusamy, Q Zhao… - …, 2020 - pmc.ncbi.nlm.nih.gov
Mutations of the IGH variable region in patients with chronic lymphocytic leukemia are
associated with a favorable prognosis, whereas cytogenetic complexity (≥ 3 unrelated …

The outcome of Chronic lymphocytic leukaemia patients with 97% IGHV gene identity to germline is distinct from cases with <97% identity and similar to those with 98 …

Z Davis, F Forconi, A Parker, A Gardiner… - British journal of …, 2016 - Wiley Online Library
IGHV gene mutational status has prognostic significance in chronic lymphocytic leukaemia
(CLL) but the percentage of mutations that correlates best with clinical outcome remains …